Patents by Inventor Dongxia Xing

Dongxia Xing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF CLOSTRIDIUM GHONII COMBINED WITH TUMOR ANGIOGENESIS INHIBITOR
    Publication number: 20240131086
    Abstract: The present disclosure provides use of Clostridium ghonii combined with a tumor angiogenesis inhibitor in preparing a pharmaceutical product for treating a tumor. The present disclosure further provides a drug for treating a tumor, where the drug includes active ingredients of Clostridium ghonii and a tumor angiogenesis inhibitor.
    Type: Application
    Filed: October 9, 2022
    Publication date: April 25, 2024
    Inventors: Yong Wang, Yuanyuan Liu, Wenhua Zhang, Yanqiu Xing, Shaopeng Wang, Dan Wang, Hong Zhu, Xinglu Xu, Shengbiao Jiang, Xiaonan Li, Jiahui Zheng, Rong Zhang, Dongxia Yang, Yuxia Gao, Shili Shao, Ting Han
  • METHODS AND COMPOSITIONS RELATED TO Th-1 DENDRITIC CELLS
    Publication number: 20190262442
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: January 7, 2019
    Publication date: August 29, 2019
    Applicant: Board of Regents, The University of Texas System
    Inventors: William K. DECKER, Elizabeth J. SHPALL, Krishna V. KOMANDURI, Dongxia XING
  • Methods and compositions related to T-1 dendritic cells
    Patent number: 9993537
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: June 12, 2018
    Assignee: Board of Regents, The University of Texas System
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
  • METHODS AND COMPOSITIONS RELATED TO Th-1 DENDRITIC CELLS
    Publication number: 20160263206
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: April 19, 2016
    Publication date: September 15, 2016
    Applicant: Board of Regents, The University of Texas System
    Inventors: William K. DECKER, Elizabeth J. SHPALL, Krishna V. KOMANDURI, Dongxia XING
  • Methods and composition related to Th-1 dendritic cells
    Patent number: 9333248
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: May 10, 2016
    Assignee: Board of Regents, The University of Texas System
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
  • METHODS AND COMPOSITION RELATED TO TH-1 DENDRITIC CELLS
    Publication number: 20140286975
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: April 9, 2014
    Publication date: September 25, 2014
    Applicant: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: William K. DECKER, Elizabeth J. SHPALL, Krishna V. KOMANDURI, Dongxia XING
  • Methods and compositions related to T-1 dendritic cells
    Patent number: 8728806
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: May 20, 2014
    Assignee: The Board of Regents, The University of Texas System
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
  • COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP
    Publication number: 20120309717
    Abstract: The present invention provides compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.
    Type: Application
    Filed: February 1, 2012
    Publication date: December 6, 2012
    Applicant: EISAI INC.
    Inventors: Vincent J. Kalish, Jie Zhang, Weizheng Xu, Jia-He Li, Amy Dongxia Xing, Qun Liu
  • METHODS AND COMPOSITIONS RELATED TO TH-1 DENDRITIC CELLS
    Publication number: 20110306948
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: December 4, 2009
    Publication date: December 15, 2011
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
  • COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP
    Publication number: 20100256095
    Abstract: The present invention provides compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.
    Type: Application
    Filed: June 18, 2010
    Publication date: October 7, 2010
    Applicant: Eisai Inc.
    Inventors: Vincent J. Kalish, Jie Zhang, Weizheng Xu, Jia-He Li, Amy Dongxia Xing, Qun Liu
  • COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP
    Publication number: 20090298837
    Abstract: The present invention provides compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.
    Type: Application
    Filed: August 13, 2009
    Publication date: December 3, 2009
    Applicant: Eisai Corporation of North America
    Inventors: Vincent J. Kalish, Jie Zhang, Weizheng Xu, Jia-He Li, Amy Dongxia Xing, Qun Liu
  • COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP
    Publication number: 20090088407
    Abstract: The present invention provides compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.
    Type: Application
    Filed: October 20, 2008
    Publication date: April 2, 2009
    Applicant: MGI GP, Inc.
    Inventors: Vincent J. Kalish, Jie Zhang, Weizheng Xu, Jia-He Li, Amy Dongxia Xing, Qun Liu
  • Compounds, methods and pharmaceutical compositions for inhibiting PARP
    Patent number: 7456178
    Abstract: The present invention provides compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.
    Type: Grant
    Filed: August 6, 2007
    Date of Patent: November 25, 2008
    Assignee: MGI GP, Inc.
    Inventors: Vincent Kalish, Jie Zhang, Weizheng Xu, Jia-He Li, Amy Dongxia Xing, Qun Liu
  • Compounds, methods and pharmaceutical compositions for inhibiting PARP
    Patent number: 7268138
    Abstract: The present invention provides compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: September 11, 2007
    Assignee: MGI GP, Inc.
    Inventors: Vincent J. Kalish, Jie Zhang, Weizheng Xu, Jia-He Li, Amy Dongxia Xing, Qun Liu